Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of orthopedic disorders
3.2.1.2 Technological advancements in bone graft materials
3.2.1.3 Rising number of surgical procedures
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of bone graft procedures
3.2.2.2 Limited reimbursement policies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Material Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Allograft
5.2.1 Demineralized bone matrix (DBM)
5.2.2 Other allografts
5.3 Synthetic
5.3.1 Polymers
5.3.2 Ceramics
5.3.3 Composites
5.3.4 Bone morphogenic proteins (BMP)
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Spinal fusion
6.3 Dental
6.4 Joint reconstruction
6.5 Foot & ankle
6.6 Craniomaxillofacial
6.7 Long bone
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Specialty clinics
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 AlloSource
9.2 Baxter International Inc.
9.3 DePuy Synthes (Johnson & Johnson Inc.)
9.4 Geistlich Pharma AG
9.5 Medtronic plc
9.6 NuVasive, Inc.
9.7 Orthofix US LLC.
9.8 OST Laboratories
9.9 Smith + Nephew
9.10 Stryker Corporation
9.11 Zimmer Biomet Holdings, Inc.
